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Introduction
Diabetes mellitus represents a disease entity that primary
care providers commonly encounter in the outpatient set-
ting. Patient visits encompass a broad range of concerns,
from optimizing management of hyperglycemia to the
sequelae of chronic disease. The third National Health
and Nutrition Exam Survey (NHANES III) 1988-1994
has reported the prevalence of diabetes mellitus type 2 in
the U.S adult population at 12.3%1. The cost of diabetes
in 1998, estimated at $77 billion2, is a formidable chal-
lenge to the health care community and third-party pay-
ers. Historically, Health Maintenance Organizations
(HMOs) have encouraged more preventative tests, proce-
dures, and exams to curtail the development of chronic
disease than indemnity plans3. The influx of patients of
all ages into these capitated plans has spurred such orga-
nizations to reconcile cost-conscious initiatives with the
expense of chronic disease using treatment algorithms.
Aetna U.S. Healthcare (USHC) has developed Healthy
Outlook Programs to manage patients with diabetes using
patient education, treatment recommendations, and a
U.S. Quality Algorithm (USQA) Diabetes Performance
Report for providers4. It is not clear whether this pro-
gram has helped patients with Type 2 diabetes achieve
improved glycemic control, receive enhanced screening,
and earlier interventions for disease complications com-
pared with indemnity patients. This pilot study seeks to
evaluate the effectiveness of managed health care initia-
tives in improving the quality of care for Type 2 diabetes.
In addition, it considers whether differences exist in the
care between capitated and indemnity diabetic patients.
Methods
A five-physician office practice affiliated with a teaching
community hospital in suburban Philadelphia served as
the site of a retrospective chart review. Patients were
identified by billing slips dated from August 1998
through February 1999. A computer audit generated a
list of all patients seen August 1999 through February
2000 with the coded diagnosis of diabetes mellitus,
ICD-9 250.00. Study participants were defined as hav-
ing diabetes mellitus type 2 if: 1) they exhibited a ran-
dom blood sugar of >126 mg/dL on more than two
occasions when seen in the primary care office in the
course of one year or 2) they received pharmacologic ther-
apy by chart documentation. Patients were evaluated
based on nine services: weight measurement, microalbu-
min, blood glucose, lipid panel, treatment of dyslipi-
demia, angiotensin converting enzyme inhibitor use,
ophthalmologic, podiatry, and nutritionist referrals. The
average weight and blood glucose levels were tabulated.
Intervention with lipid-lowering agents and angiotensin
converting enzyme inhibitor were noted as present or
absent. Referrals to ophthalmology, podiatry, and dieti-
cian services were noted as present or absent. 
Patients were excluded if they were enrolled in a Preferred
Provider Organization (PPO), Medicare, or Medicare
HMO; changed insurance in less than one year; history of
diabetes mellitus type 1, pancreatitis, glucocorticoid use;
or insufficient documentation for diagnosis.
The data was merged with the statistical program, SPSS.
Statistical analysis used the student’s two-tailed t test to
establish differences between the two groups. Statistical
significance was noted for a p value <0.05.
Results
The cohort comprised 18 capitated and 14 indemnity
patients, and N = number of patient visits. Table 1
reflects demographic data of the patients. The average
age of capitated patients was 55 years while indemnity
patients were 58 years, p value = 0.057. Capitated
patients weighed on average 223 lb. +/- 57 lb. while
indemnity patients weighed 185 lb.+/- 52 lb, p <0.0001.
Glycemic control was evaluated based on the number of
laboratory draws for each group. The average blood glu-
cose for capitated patients was 181+/- 69 mg/dL while
the average blood glucose for indemnity patients was 158
+/- 54 mg/dL; p value = 0.029. 
The management of dyslipidemia between the two groups
was noteworthy: although the average total cholesterol of
each group was nearly the same, 23% of indemnity patients
versus 46% of capitated patients were receiving medical
17
Original Contribution
A Pilot Study of Diabetes Management in the Managed Care Setting
Rachel Wagman, MD, Resident Department of Internal Medicine 1997-2000
and Michael Steinberg, MD, MPH
1
Wagman: A Pilot Study of Diabetes Management in the Managed Care Setting
Published by Jefferson Digital Commons, 2001
(Continued on next page)
treatment (p=0.005). Despite treatment differences, the
data, although not statistically significant, showed a trend
that neither group achieved goal cholesterol <200mg/dL,
LDL <130mg/dL, or LDL < goal 100 mg/dL.
The utilization of microalbumin testing was low for both
groups; 7.2% of capitated patients versus 6.7% of indem-
nity patients were screened; those with positive findings
were under treatment with an angiotensin converting
enzyme inhibitor. Ophthalmology screening revealed
that only 6.7% indemnity patients were referred as
opposed to 20% of capitated patients, p=0.011. Podiatry
and nutrition evaluations revealed a small referral rate
and the difference between the two cohorts was not sig-
nificant (data not shown). 
Discussion
The data reveal that capitated patients tended to be more
overweight with inferior glycemic control compared with
indemnity patients. This may reflect gender differences:
nearly all indemnity participants were women while the
capitated patients were equally divided between men and
women. Note that the average blood sugar reflects both
fasting and random values for each group. The more pro-
nounced hyperglycemia in the capitated group may
reflect the higher body mass index and thus, greater
insulin resistance. The capitated group fared better in
decisions for pharmacologic therapy of dyslipidemia as
well as referral to ophthalmology. This may reflect the
practitioner’s lower threshold to screen and treat patients
with an elevated body mass index. However, one would
expect this to extend to other services that diabetics seek,
including screening for nephropathy and recommenda-
tion to other health care providers for a multi-specialty
approach to care. Differences were not significant
between the groups in screening for nephropathy, use of
angiotensin converting enzyme inhibitor, or other sub-
specialty referrals. 
This pilot study had several limitations. The number of
patients in each cohort limited meaningful comparisons
between the two groups. Chart reviews are contingent on
the completeness of the practitioner’s notes with treat-
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Capitated Indemnity p value
Age (yrs) 55 58 0.057
Male 9 2
Female 9 12
Weight (lb) 223 185 0.0001
SD Weight 47 52
Average 181 157 0.029
Glucose
(mg/dL)
SD (mg/dL) 69 54
Capitated Indemnity p value
Average Total Cholesterol
(mg/dL) 218 220 0.753
SD (mg/dL) 34 44
Total Cholesterol Treated
N=# pt visits 32/70 21/90
% tx'd 46% 23% 0.005
Total Cholesterol at Goal <200 mg/dL
N= # pt visits 22/62 24/75
% at goal 36% 32% 0.667
Average LDL
(mg/dL) 136 145 0.142
SD(mg/dL) 31 35
LDL at Goal <130 mg/dL
N=# pt visits 22/51 26/63
% at goal 46% 54% 0.841
LDL at Goal <100 mg/dL
N=# pt visits 6/51 2/47
% at goal 11% 4% 0.175
Table 2. Cholesterol and LDL Data
Table 1. Demographic Data
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ment plan and follow-up correspondence from the sub-
specialist. This evaluation did not include duration of
time that the patients were diabetic; newly diagnosed dia-
betics may not have had the disease of sufficient time to
allow for all referrals and interventions to be examined.
Interestingly, ADA guidelines for glycemic and dyslipi-
demia management have not been strictly followed for
either group of patients. Short office visits may limit the
types of interventions that can be pursued for diabetes,
let alone any comorbidities. A solution may be the use of
a mid-level practitioner who could assist in the care in
managing these patients. This would allow for follow-up
between physician visits to review glycemic control,
highlight annual screening measures, and review referral
notes from subspecialists. This also could serve as a time
to reinforce dietary habits. Such enhancement of contact
between health care providers and patients may allow for
earlier intervention in the management of complication
of diabetes. The publication of improved outcomes of
diabetic patients who receive additional health care may
provide momentum to include mid-level practitioners in
the care of these individuals.
Special thanks to Christine Steinberg, MS for statistics
and Matthew Killion, MD for review of the manuscript.
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